Fuji Yakuhin Co., Ltd.
- Biotech or pharma, therapeutic R&D
Our company operates various businesses under an integrated pharmaceutical framework in Japan.
We have previously developed our in-house products such as the xanthine oxidase inhibitor “Topiloric® tablets” and the selective uric acid reabsorption inhibitor “Urece® tablets”.
As part of our efforts to strengthen our development pipeline, we are looking for products that can be licensed in Japan, especially those with a POC.
Address
SaitamaJapan
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}